These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8664469)

  • 1. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.
    Gallagher JM; Brown ME; Gasior TA
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
    Terrell MR; Walenga JM; Koza MJ; Pifarré R
    Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT.
    Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK
    Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting.
    Jansen PG; Baufreton C; Le Besnerais P; Loisance DY; Wildevuur CR
    Ann Thorac Surg; 1996 May; 61(5):1363-6. PubMed ID: 8633942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic thromboses after cardiopulmonary bypass: is it thrombin or antithrombin?
    Tanaka KA; Sniecinski R
    Anesthesiology; 2006 Aug; 105(2):428; author reply 428-9. PubMed ID: 16871082
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of aprotinin during pediatric heart surgery].
    Martín Burcio S; Valiño González J; Domínguez F; Díaz Balda J; Martínez M; Vellibre D
    Rev Esp Anestesiol Reanim; 2001 May; 48(5):212-6. PubMed ID: 11412731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrinsic pathway--associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass.
    Gu YJ; Huyzen RJ; van Oeveren W
    Anesth Analg; 1996 Aug; 83(2):433. PubMed ID: 8694335
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of aprotinin in heparinized and nonheparinized patients.
    Levy JH
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):38S-42S. PubMed ID: 15368205
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery.
    Dixon B; Campbell DJ; Santamaria JD
    Intensive Care Med; 2008 Jul; 34(7):1216-23. PubMed ID: 18301879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin.
    Alston TA
    Int Anesthesiol Clin; 2004; 42(4):81-91. PubMed ID: 15577702
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids.
    Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y
    Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplification of the Bentall procedure with surgical and biological innovations.
    Loisance D
    Eur J Cardiothorac Surg; 1994; 8(11):613-5. PubMed ID: 7534466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin: topical or systemic delivery in left ventricular assist device implantation.
    Hariawala MD
    Circulation; 1997 Oct; 96(8):2736-7. PubMed ID: 9355922
    [No Abstract]   [Full Text] [Related]  

  • 19. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of heparin-bonded circuits: when a meta-analysis does not clear out the clouds.
    Ranucci M
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):703-4; author reply 704-5. PubMed ID: 18667328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.